ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Chairmen Unhappy Over Contracts They Missed, NCI Protocol Review

January 13, 1978

Medicare Covers All PET Scans For Cancer In New Program

May 26, 2006

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

August 30, 2013

ACS Expresses Concern About “Fletcher Report” On Mammography

May 7, 1993

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012